Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-09-12 21:32:51
Reporting Period:
Accepted Time:
2019-09-12 21:32:51
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1213809 Dyadic International Inc DYAI Biological Products, (No Disgnostic Substances) (2836) 450486747
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761230 Ronen Tchelet 140 Intracoastal Pointe Drive
Suite 404
Jupiter FL 33477-5094
Vp Of Research And Bus. Dvlpmt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-10 10,000 $1.41 10,000 No 4 M Direct
Common Stock Disposition 2019-09-10 10,000 $5.27 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-09-10 10,000 $0.00 10,000 $1.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2015-12-31 2024-04-30 No 4 M Direct
  1. The sale of the shares of Class A Common Stock were made pursuant to Rule 10b5-1 trading plan adopted on June 11, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.43, inclusive. The reporting person undertakes to provide to Dyadic International, Inc., any security holder of Dyadic International, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of footnote (1) to this Form 4.